REGENERON THERAPEUTICS, INC. (NASDAQ: REGN) INVESTOR ALERT: Investors With Large Losses in Regeneron Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Regeneron Therapeutics, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, inclusive. For more information, submit a form at Regeneron Therapeutics, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at palloc ...